Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations

BACKGROUND: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) are the standard treatment of advanced, EGFR-mutant non-small-cell lung cancer (NSCLC). Usually, radiographic assessment of response to chemotherapy is performed after the patient completes the second course of trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Salvador-Coloma, Carmen, Lorente, David, Palanca, Sarai, Simarro, Javier, Mancheño, Nuria, Sandoval, Juan, Lahoz, Agustín, Juan, Óscar
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2018
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906304/
https://ncbi.nlm.nih.gov/pubmed/29707288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.02.30
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars